reGional Network for Acute Myocardial Infarction

NCT03928119 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7102

Last updated 2022-06-01

No results posted yet for this study

Summary

Incidence of ST-segment Elevation Myocardial Infarction (STEMI) is rising and the existing emergency medical aid system for STEMI was not enough for timely perfusion treatment. No existing research with high-quality data focuses on the characteristic of STEMI incidence and regional network construction. Aiming of Guangdong GAMI(reGional network for Acute Myocardial Infarction) project is to establish effective collaborative regional network system for STEMI patients treatment.

Conditions

Interventions

BEHAVIORAL

public education and network construction

Publication education includes multiple methods of acute myocardial infarction knowledge education. Network construction includes regional connection of ST-Segment Elevation Myocardial Infarction patients transfer for percutaneous coronary intervention treatment, as well as physicians skill improvement in primary hospital.

Sponsors & Collaborators

  • Maoming People's Hospital

    collaborator OTHER
  • Dongguan People's Hospital

    collaborator OTHER_GOV
  • Southern Medical University, China

    collaborator OTHER
  • Guangzhou Panyu Central Hospital

    collaborator OTHER
  • Yangjiang People's Hospital

    collaborator OTHER
  • Shenzhen People's Hospital

    collaborator OTHER
  • Longyan First Hospital, Affiliated to Fujian Medical University

    collaborator UNKNOWN
  • Guangdong Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Yan Liang, MD · Maoming People's Hospital

  • Jianfeng Ye, MD · Dongguan People's Hospital

  • Yunzhao Hu, MD · The first People's Hospital of Shunde, Foshan

  • Wenzhu Zhang, MD · Guangzhou Panyu Central Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-01
Primary Completion
2020-02-28
Completion
2024-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03928119 on ClinicalTrials.gov